All posts tagged
Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II
Top European VC and CRO fund Young Metabolic Disease Biotech
These are our 10 Most Read Biotech Articles of 2016
What does ‘Anti-Aging Treatment’ mean in Biotech?
Needle-Free Diabetes Monitoring: Interview with the Co-Founder of GlucoWise
Can Biotech Stop the Diabetes Epidemic? Reviewing the Hottest Technology
A €103M Target to Reduce Drug Dosage with a Slow-Release Tech
Sanofi & Google Joint Venture could Revolutionize Diabetes
Roche debuts new MedTech for needle-free management of Diabetes
Mobile Pancreas to Change Life of Diabetics in New EU Programme
Transdermal Drug Delivery: Will Skin patches Replace Pills and Injections?
Black Friday Ruin as TWO Biotechs Fail in Phase III Trials
Labiotech UG, All Rights Reserved -
Send this to friend